Compare GIB & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIB | BAX |
|---|---|---|
| Founded | 1976 | 1931 |
| Country | Canada | United States |
| Employees | N/A | 37500 |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.9B |
| IPO Year | 1999 | 1994 |
| Metric | GIB | BAX |
|---|---|---|
| Price | $73.50 | $26.74 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 9 |
| Target Price | ★ $112.00 | $21.00 |
| AVG Volume (30 Days) | 470.7K | ★ 7.6M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.70% | 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $8.33 | $1.96 |
| Revenue Next Year | $2.96 | $2.22 |
| P/E Ratio | ★ $13.59 | $128.79 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $59.63 | $15.73 |
| 52 Week High | $97.55 | $30.00 |
| Indicator | GIB | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 61.41 |
| Support Level | $70.05 | $18.58 |
| Resistance Level | $75.34 | $30.00 |
| Average True Range (ATR) | 2.26 | 1.18 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 58.68 | 50.35 |
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.